Market closedNon-fractional

Applied Therapeutics/APLT

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About Applied Therapeutics

Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.

Ticker

APLT

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

New York, United States

Employees

26

APLT Metrics

BasicAdvanced
$500M
Market cap
-
P/E ratio
-$1.91
EPS
1.88
Beta
-
Dividend rate
$500M
1.88
1.799
1.756
0.052
0.51
-51.57%
-612.33%
-931.915
7.45
7.45
-6.625
-104.47%
24.35%
-25.65%

What the Analysts think about APLT

Analyst Ratings

Majority rating from 5 analysts.
Buy

APLT Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
-83,900.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$100K
-98.99%
Net income
-$84M
-29.91%
Profit margin
-83,900.00%
6,839.10%

APLT Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 320.06%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.37
-$0.47
-$0.34
-$0.67
-
Expected
-$0.27
-$0.26
-$0.23
-$0.16
-$0.18
Surprise
39.62%
81.23%
49.12%
320.06%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Applied Therapeutics stock?

Applied Therapeutics (APLT) has a market cap of $500M as of July 05, 2024.

What is the P/E ratio for Applied Therapeutics stock?

The price to earnings (P/E) ratio for Applied Therapeutics (APLT) stock is 0 as of July 05, 2024.

Does Applied Therapeutics stock pay dividends?

No, Applied Therapeutics (APLT) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Applied Therapeutics dividend payment date?

Applied Therapeutics (APLT) stock does not pay dividends to its shareholders.

What is the beta indicator for Applied Therapeutics?

Applied Therapeutics (APLT) has a beta rating of 1.88. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Applied Therapeutics stock

Buy or sell Applied Therapeutics stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing